Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells

Diabetes Research and Clinical Practice

Volumn 44, Issue 2, 1999, Pages 83-92

  Kaneko, K ^a   Shirotani, T ^a   Araki, E ^a   Matsumoto, K ^a   Taguchi, T ^a   Motoshima, H ^a   Yoshizato, K ^a   Kishikawa, H ^a   Shichiri, M ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Glucagon secretion; In R1 G9 cells; Insulin; Pancreatic alpha cells; PI3 kinase

Indexed keywords

GLUCAGON; INSULIN; PHOSPHATIDYLINOSITOL KINASE; WORTMANNIN;

ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCAGON RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PANCREAS ISLET ALPHA CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; KINETICS; PHOSPHOPROTEINS; PHOSPHORYLATION; TIME FACTORS;

EID: 0032868694     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00021-2     Document Type: Article

References (42)

1. Lefèbvre P.J. Glucagon and its family revisited. Diabetes Care. 18:1995;715-730.
2. Shichiri M., Kawamori R., Abe H. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes. 28:1979;272-275.
3. Kawamori R., Shichiri M., Kikuchi M., Yamasaki Y., Abe H. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Diabetes. 29:1980;762-765.
4. Paolisso G., Sgambato S., Torella R. et al. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 66:1988;1220-1226.
5. Hamaguchi T., Fukushima H., Uehara M. et al. Abnormal glucagon response to arginine and normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Diabetologia. 34:1991;801-806.
6. Kisanuki K., Kishikawa H., Araki E. et al. Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion. Diabetologia. 38:1995;422-429.
7. Sun X.J., Rothenberg P., Kahn C.R. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:1991;73-77.
8. Araki E., Lipes M.A., Patti M.E. et al. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature. 372:1994;186-190.
9. White M.F., Kahn C.R. The insulin signaling system. J. Biol. Chem. 269:1994;1-4.
10. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocrinol. Rev. 16:1995;117-142.
11. Zick Y., Kasuga M., Kahn C.R., Roth J. Characterization of insulin-mediated phosphorylation of the insulin receptor in a cell-free system. J. Biol. Chem. 258:1983;75-80.
12. Lavan B.E., Kuhne M.R., Garner C.W. et al. The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. J. Biol. Chem. 267:1992;11631-11636.
13. Carpenter C.L., Auger K.R., Chanudhuri M. et al. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J. Biol. Chem. 268:1993;9478-9483.
14. Yoshimura R., Araki E., Ura S. et al. Mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling. Diabetes. 46:1997;929-936.
15. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:1994;3568-3573.
16. Clarke J.F., Young P.W., Yonezawa K., Kasuga M., Holman G.D. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300:1994;631-635.
17. Shepherd P.R., Nave B.T., Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 305:1995;25-28.
18. Phung T.L., Roncone A., Jenses K.L.M., Sparks C.E., Sparks J.D. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J. Biol. Chem. 272:1997;30693-30702.
19. Sutherland C., O'Brien R.M., Granner D.K. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. J. Biol. Chem. 270:1995;15501-15506.
20. Agati J.M., Yeagley D., Quinn P.G. Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 273:1998;18751-18759.
21. Philippe J., Mojsov S., Drucker D.J., Habener J.F. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas. Endocrinology. 119:1986;2833-2839.
22. Bell G.I., Santerre R.F., Mullenbach G.T. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature. 302:1983;716-718.
23. 2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur. J. Endocrinol. 138:1998;344-352.
24. Fukui Y., Hanafusa H. Phosphatidylinositol kinase activity associates with viral p60src protein. Mol. Cell. Biol. 9:1989;1651-1658.
25. Nishino T., Kodaira T., Shin S. et al. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin. Chem. 27:1981;1690-1697.
26. Heller-Harrison R.A., Morin M., Guilherme A., Czech M.P. Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J. Biol. Chem. 271:1996;10200-10204.
27. Takaki R., Ono J., Nakamura M. et al. Isolation of glucagon-secreting cell lines by cloning insulinoma cells. In Vitro Cell Dev. Biol. 22:1986;120-126.
28. Shennan K.I., Holst J.J., Docherty K. Proglucagon expression, posttranslational processing and secretion in SV40-transformed islet cells. Mol. Cell. Endocrinol. 67:1989;93-99.
29. Pipeleers D.G., Schuit F.C., in't Veld P.A. et al. Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology. 117:1985;824-833.
30. Rahn T., Ridderstrale M., Tornqvist H. et al. Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes: Studies using the selective inhibitor wortmannin. FEBS Lett. 350:1994;314-318.
31. Cross D.A., Alessi D.R., Vandenheede J.R., McDowell H.E., Hundal H.S., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303:1994;21-26.
32. Yao R., Cooper G.M. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
33. Arcaro A., Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296:1993;297-301.
34. Philippe J. Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. J. Clin. Invest. 84:1989;672-677.
35. Philippe J., Morel C., Cordier-Bussat M. Islet-specific proteins interact with the insulin-response element of glucagon gene. J. Biol. Chem. 270:1995;3039-3045.
36. Krook A., Whitehead J.P., Dobson S.P. et al. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects. J. Biol. Chem. 272:1997;30208-30214.
37. +-ATPase activity in cultured rat skeletal muscle cells. J. Biol. Chem. 272:1997;23653-23658.
38. Begum N., Ragiola L. cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells. J. Biol. Chem. 271:1996;31166-31171.
39. Valtorta F., Benfenati F., Greengard P. Structure and function of the synapsins. J. Biol. Chem. 267:1992;7195-7198.
40. King M.M., Huang C.Y., Chock P.B. et al. Mammalian brain phosphoproteins as substrates for calcineurin. J. Biol. Chem. 259:1984;8080-8083.
41. 2+/calmodulin-dependent protein kinase II and synapsin I-like protein in mouse insulinoma MIN6 cells. Endocrinology. 136:1995;3784-3793.
42. Ebihara K., Fukunaga K., Matsumoto K., Shichiri M., Miyamoto E. Cyclosporin A stimulation of glucose-induced insulin secretion in MIN6 cells. Endocrinology. 137:1996;5255-5263.